Acquired Thrombotic Thrombocytopenic Purpura After ChAdOx1 nCoV-19 Vaccine: A Case Report
COVID-19, the illness caused by SARS-CoV-2, continues to cause significant morbidity and mortality across the world. An important step in overcoming SARS-CoV-2 is the global vaccination plan. Cases of acquired thrombotic thrombocytopenic purpura (aTTP) have been recently described after SARS-CoV-2 v...
Saved in:
| Main Authors: | Domenica Caramazza, Marco Salvini, Vincenzo Saturni, Francesco Ripamonti, Michele Merli, Benedetta Bianchi, Stefania Agnoli, Davide Sirocchi, Barbara Mora, Elena Galfrascoli, Francesco Passamonti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2022-07-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2021.0110 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cutaneous Leukocytoclastic Vasculitis after ChAdOx1 nCoV-19 Vaccine
by: Mansoor C. Abdulla
Published: (2022-10-01) -
Challenges in diagnosing thrombotic thrombocytopenic purpura
by: Jeremy W. Jacobs, et al.
Published: (2025-07-01) -
Thrombotic Thrombocytopenic Purpura Associated with Pazopanib
by: Umer Syed, et al.
Published: (2018-01-01) -
Thrombotic Thrombocytopenic Purpura in Pediatric Patients
by: Niki Shrestha, et al.
Published: (2025-04-01) -
Thrombotic Thrombocytopenic Purpura in Dengue Fever
by: Tze Yuan Tee, et al.
Published: (2021-07-01)